International Summer School

Information for applicants in response to the coronavirus

Due to the current restrictions on travel and large gatherings and to actively minimise the impact and spread of the coronavirus, IMB has taken the difficult decision to cancel the 2020 International Summer School (ISS). We apologize for any inconvenience and thank you for your understanding.

We will inform applicants of this decision and will announce the new dates of the ISS 2021 on this page when new dates are decided. Please be informed that we will not keep the applications submitted for the ISS 2020 and if you wish to apply next year to the ISS 2021 you will need to submit a new application.

IMB prioritises the health and safety of all our employees and visitors. For further information about how IMB is handling the current coronavirus situation, please see our updated news page.


The International Summer School (ISS) is a 6-week programme with a focus on “Gene Regulation, Epigenetics and Genome Stability”. It is coordinated by the Institute of Molecular Biology (IMB).

 

The ISS offers outstanding and enthusiastic undergraduate and Master's students from all over the world the opportunity to acquire excellent practical skills and hands-on training from leading scientists in molecular biology.
If this describes you then please keep reading to find out more about the ISS and how to apply.

The International Summer School has a clearly defined and unique profile that will provide you with interdisciplinary education in the following fields:

  • Epigenetics
  • Gene Regulation
  • DNA Damage & Genome Stability
  • Developmental Biology
  • Systems Biology & Bioinformatics  
  • Translational Research

The programme of the ISS covers a period of 30 workdays.

For more information on Mainz and what the city has to offer, please check Working & Living in Mainz.

If you have any questions about the ISS, please visit our FAQs page. You can also contact us using the details on the contact page. Keep an eye on our webpage or follow us on Twitter or Facebook for further updates.